We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pre-transplantation and post-transplantation serum bone alkaline phosphatase levels in renal transplant patients.
- Authors
Gümüş, Alper; Öztürk, Savaş; Düz, Muhammed Emin; Sari, Soner; Koldaş, Macit; Akaydin, Mükerrem
- Abstract
Bone Alkaline Phosphatase (BAP) reflects the biosynthetic activity of the osteoblasts. End-stage renal disease and renal transplantation have effects on bone metabolism. The aim of this study was to evaluate serum BAP levels in pre-transplantation (pre-tx) and post-transplantation (post-tx) samples obtained from patients who underwent a renal transplantation. Forty end-stage renal disease patients (16 male and 24 female) undergoing transplantation and 40 healthy individuals (20 female and 20 male) volunteered for this study. The serum samples were obtained before the onset of immunosuppressive treatment and two months after renal transplantation. Serum BAP levels were measured by Ostease Kit (Beckman Coulter, California, USA) at DXI 800 immunoassay autoanalyzer. There were significant differences between control group and pre-tx group (p=0.015) and between control group and post-x group (P<0.001). The serum BAP levels were lower in the post-tx group than that of the control group the control group, but this difference was not statistically significant (p=0.023). These results suggest that osteoblast activity is suppressed during chronic renal failure and transplantation worsens osteoblastic inactivity, thus causing to enter a non-dynamic state the bone. BAP may be a useful parameter for assessing the metabolic status of bone before and after renal transplantation.
- Subjects
SERUM; BONES; ALKALINE phosphatase; KIDNEY transplant patients; METABOLISM
- Publication
Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi, 2014, Vol 31, Issue 2, p91
- ISSN
1309-4483
- Publication type
Article
- DOI
10.5835/jecm.omu.31.02.006